Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike
September 4, 2016
Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.
Mark Baum / Imprimis Pharmceuticals
Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.
"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.
"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."
Dogs Are Forced To Wear The Things They Steal — And It’s Hilarious
Her Neighbor Invited Her To An Art Show — Then Asked Her To Wear One Specific Dress
Viral Dog Rescue In Kazakhstan Now Honored With Statue
At First Glance, This Photo Looks Like An Optical Illusion… But It’s Something Much More Incredible
'Anyone Who Lets Him Pay Is Fired': 81-Year-Old Man Becomes 'Grandpa' At Local Dunkin'
This Dolphin Jumped So High It Looks Photoshopped — But It’s Not
'Get In Here And Say That To My Face!' — And The Husky Does Exactly That
Baby Warthog Does The World's Best Side Step Past Hungry Lions
Imagine Being On The Other End Of This Zoom Call…
Rare Footage Captures Something Incredible During A Whale Birth
Heroic Residents In Hawaii Rescue 98-Year-Old Woman Trapped In Rising Floodwaters
